Literature DB >> 9240698

Selection of influenza A and B viruses for resistance to 4-guanidino-Neu5Ac2en in cell culture.

J M Colacino1, W G Laver, G M Air.   

Abstract

The reassortant influenza viruses, A/NWS-G70c with N9 neuraminidase (NA) and B/HK/8/73 (HG) with B/Lee/40 NA, were selected for resistance to 4-guanidino-Neu5Ac2en (4-GuDANA) by passaging the virus in stepwise increases in the concentration of 4-GuDANA. In the NA of resistant viruses, the absolutely conserved Glu 119, which lies in a pocket beneath the active site of the enzyme and interacts with the guanidinium moiety of 4-GuDANA, was changed to Gly. The mutant NA was >200-fold more resistant to 4-GuDANA than was the wild-type enzyme. During 72 h in cell culture, resistant A and B viruses displayed much less NA activity than did wild-type viruses but did undergo multicycle replication. While emergence of resistance to 4-GuDANA has not been observed in vivo, these results demonstrate that the development of resistance is possible and can be mediated by a single amino acid change in the active site of the viral NA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9240698     DOI: 10.1086/514179

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  6 in total

Review 1.  Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.

Authors:  Andrew J Burnham; Tatiana Baranovich; Elena A Govorkova
Journal:  Antiviral Res       Date:  2013-09-04       Impact factor: 5.970

Review 2.  Zanamivir.

Authors:  S L Waghorn; K L Goa
Journal:  Drugs       Date:  1998-05       Impact factor: 9.546

3.  Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance.

Authors:  Margaret Okomo-Adhiambo; Gail J Demmler-Harrison; Varough M Deyde; Tiffany G Sheu; Xiyan Xu; Alexander I Klimov; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2010-03-01       Impact factor: 5.191

4.  In vitro selection of influenza B viruses with reduced sensitivity to neuraminidase inhibitors.

Authors:  S Hatakeyama; M Ozawa; Y Kawaoka
Journal:  Clin Microbiol Infect       Date:  2010-07-15       Impact factor: 8.067

5.  Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.

Authors:  C Y Tai; P A Escarpe; R W Sidwell; M A Williams; W Lew; H Wu; C U Kim; D B Mendel
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

6.  Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility.

Authors:  R Farrukee; A E Zarebski; J M McCaw; J D Bloom; P C Reading; A C Hurt
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.